Patents
Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
08/2004
08/19/2004WO2004046090A3 Aryl ureido derivatives and their medical use
08/19/2004WO2003049702A8 Vanilloid receptor ligands and their use in treatments
08/19/2004WO2003032912A8 Treatment of cns disorders using cns target modulators
08/19/2004US20040162427 Substituted 2,6-diamino-3,5-dicyano-4-aryl-pyridines and their use as adenosine receptor-selective ligands
08/19/2004US20040162426 TNF (tumor necrosis factor); for treating conditions such as rheumatoid and osteoarthritis, corneal, epidermal or gastric ulceration; tumor metastasis or invasion; periodontal disease and bone disease
08/19/2004US20040162321 For therapy of disease characterized by inflammatory, allergic, or proliferative processes
08/19/2004US20040162319 For prophylaxis and therapy of thrombotic conditions including coronary artery and cerebrovascular diseases
08/19/2004US20040162317 For therapy of diseases mediated by the inhibition of histone deacetylase, such as cancer
08/19/2004US20040162287 Substituted cyclohexane-1,4-diamine compounds
08/19/2004US20040162285 Anti-infective agents
08/19/2004US20040162283 Acyclic and cyclic guanidine-and acetamidine derivatives, their preparation and their use as pesticides, esp. as parasiticides
08/19/2004US20040162281 Pyridine ring containing biaryl compound useful to treat and/or prevent clotting disorders, and as antiinflammatory and anticoagulant agents
08/19/2004US20040161441 Containing permethrin, imidacloprid and n-methylpyrrolidone; killing ticks and fleas; skin friendly, low toxicity; storage stability
08/19/2004US20040161404 Method for producing coupling compound
08/19/2004US20040158936 Compositions and methods for dyeing keratinous fibers
08/19/2004DE10305391A1 Preparation of 1-(pyridinyl)-1,1-dialkoxy-1-aminoethane derivatives involves reacting acetylpyridine tosyl oxime with mixture of alkali metal alkoxide or hydroxide or alkaline earth metal alkoxide or hydroxide with alcohol
08/19/2004CA2515516A1 Carboxylic acid compounds
08/19/2004CA2515235A1 Bis(hetero)aryl carboxamide derivatives for use as pgi2 antagonists
08/19/2004CA2515027A1 Metal ion chelators and therapeutic use thereof
08/19/2004CA2513915A1 New arylpiperazinyl compounds
08/19/2004CA2513408A1 Mono-acylated o-phenylendiamines derivatives and their use against cancer
08/18/2004EP1447666A2 Biospecific binding reactants labeled with new luminescent lanthanide chelates and their use
08/18/2004EP1447396A1 Phthalic acid diamide derivatives, agriculture and horticultural insecticides, and a method for application of the insecticides
08/18/2004EP1446399A1 Piperazine derivatives having sst1 antagonistic activity
08/18/2004EP1446382A1 Anthranilic acid amides and their use as vegf receptor tyrosine kinase inhibitors
08/18/2004EP1446381A1 Anthranilic acid amides and pharmaceutical use thereof
08/18/2004EP1446379A1 Aryl aniline beta-2 adrenergic receptor agonists
08/18/2004EP1446375A1 Dihalogenpropene compounds, method for the production thereof, agents containing said compounds and the use thereof as pest control agents
08/18/2004EP1446371A1 Method for the production of vinyl-arenes, -heteroarenes and 1,3-dienes from aryl-, heteroaryl- or vinyl-carboxylic acid derivatives
08/18/2004EP1446224A2 Aromatic compounds containing nitrogen and p-functionalized amines, the production thereof and their use in catalytic reactions
08/18/2004EP1446116A1 Inhibitors of dipeptidyl peptidase iv
08/18/2004EP1446115A2 Cyanoalkylamino derivatives as protease inhibitors
08/18/2004EP1359887A4 Primary intermediates for oxidative coloration of hair
08/18/2004EP1294366B1 Pharmaceutical compounds for treating copd
08/18/2004EP1268429B1 Vitronectin receptor antagonist bicyclic compounds, preparation method and compositions containing same
08/18/2004EP1187814B1 5-phenyl-pyrimidine derivatives
08/18/2004EP1086082B1 Arylsubstituted olefinic amines and their use as cholinergic receptors agonists
08/18/2004EP0984928A4 Aromatic and heterocyclic nitrato derivatives
08/18/2004EP0944599B1 Triarylethanes useful as pde iv inhibitors
08/18/2004CN1522248A Novel butadiene derivatives, process for preparation of the same and intermediates for the synthesis thereof
08/18/2004CN1522244A Anthranilic acid amides, method for the production thereof, their use as antiarrhythmia agents, and pharmaceutical preparations thereof
08/18/2004CN1521155A Functional additive having UV-absorbing substituent and ink composition containing the same
08/18/2004CN1162430C High-tension condensed ring nicotine analogue, preparation process and use thereof
08/18/2004CN1162423C Trioxane storage method and trioxane compositions
08/18/2004CN1162405C Substd. benzoyl ketones, methods for producing them and their use as herbicides
08/18/2004CN1162404C Synthesis of intermediates useful in preparing tricyclic compounds
08/17/2004US6777557 Method and composition for rejuvenating cells, tissues organs, hair and nails
08/17/2004US6777556 Process for preparing 2-haloalkylnicotinic acids
08/17/2004US6777552 From an ester derivative or protected ester derivative of the statin by using calcium hydroxide
08/17/2004US6777532 Polymers and oligomers, their synthesis, and electronic devices incorporating same
08/17/2004US6777432 Pharmaceutical uses and synthesis of nicotinamides
08/17/2004US6777431 Non-convalent thrombin inhibitors
08/17/2004US6777414 Nitrogen-containing heterocyclic compounds and benamide compounds and drugs containing the same
08/17/2004US6776994 Synergistic mixtures
08/17/2004CA2292921C Aryl carboxylic acid and tetrazole derivatives
08/17/2004CA2254658C New naphtalene compounds, their method of preparation and pharmaceutical compositions containing these compounds
08/12/2004WO2004067673A1 Electrochromic compounds
08/12/2004WO2004067498A2 Aryl alkyl carbamate derivatives production and use thereof in therapy
08/12/2004WO2004067489A2 Hydroxyl compounds and compositions for cholesterol management and related uses
08/12/2004WO2004067482A2 Substituted anilide ligands for the thyroid receptor
08/12/2004WO2004067007A1 NEW CRYSTALLINE MODIFICATION OF 2-(3,5-BIS-TRIFLUOROMETHYL-PHENYL)-N-[6-(1,1-DIOXO-1λ6-THIOMORPHOLIN-4-YL)-4(4-FLUORO-2-METHYL-PHENYL)-PYRIDIN-3-YL]-N-METHYL-ISOBUTYRAMIDE
08/12/2004WO2004066998A1 Stable solid medicinal composition for oral administration
08/12/2004WO2004056762A3 Novel aminobenzophenone compounds
08/12/2004WO2004052280A3 Anti-angiogenic compounds and their use in cancer treatment
08/12/2004WO2004043392A3 Mucin synthesis inhibitors
08/12/2004WO2004032908A3 Method of inhibiting angiogenesis
08/12/2004US20040158076 Tyrosine derivatives
08/12/2004US20040158074 Biphenyl sulfonamides as antiinflammatory agents and administering and antipyretics
08/12/2004US20040158073 Process for preparing pyridine-substituted amino ketal derivatives
08/12/2004US20040158067 Binding antagonist and arylpyridine for antiinflammatory agents, cardiovascular disorders and antagonist or agonist and for immunology
08/12/2004US20040158062 Process for the production of quinazolines
08/12/2004US20040157902 Integrin antagonists
08/12/2004US20040157881 Function regulator for retinoid relative receptor
08/12/2004US20040157866 Amide compounds
08/12/2004US20040157865 exhibit activity in animal models of hyperalgesia and colitis, and are useful for the treatment and prevention of pain conditions in humans including arthritis, and for the treatment of irritable-bowel syndrome
08/12/2004US20040157842 for potentiation of glutamate receptor function; treating a cognitive disorder; a neuro-degenerative disorder; age-related dementia; age-induced memory impairment; other psychiatric disorders
08/12/2004US20040157836 Sulfonamides having antiangiogenic and anticancer activity
08/12/2004US20040157829 useful in the treatment of central or peripheral nervous system disorders(e.g., migraine, ataxia, Parkinson's disease, bipolar disorders, epilepsy, hearing and vision loss, Alzheimer's disease, etc.) and as neuroprotective agent
08/12/2004US20040157818 antagonism to chemokine receptor CXCR4 for treatment of rheumatism or cancer metastasis
08/12/2004US20040157806 4-Dedimethylamino tetracycline compounds
08/12/2004US20040157799 Pharmaceutical uses of bisphosphonates
08/12/2004US20040157741 Benzoylsulfonamides and sulfonylbenzamidines for use as antitumour agents
08/12/2004DE10304343A1 Production of 5-alkoxyoxazoles useful as vitamin B6 intermediates comprises heating an alpha-isocyano alkanoate ester in the presence of a high molecular weight amine
08/12/2004DE10302452A1 Carbonylamino-substituierte Acyl-phenyl-harnstoffderivate, Verfahren zu deren Herstellung und deren Verwendung Carbonylamino-substituted acyl-phenyl-urea derivatives, processes for their preparation and their use
08/12/2004CA2511941A1 Aryl alkyl carbamate derivatives production and use thereof in therapy
08/12/2004CA2510064A1 Electrochromic compounds
08/11/2004EP1445251A1 Aminoacetonitrile derivative, agricultural and horticultural insecticitde containing the same, and use thereof
08/11/2004EP1444228A2 Substituted heteroarylalkanoic acids and their use as aldose reductase inhibitors
08/11/2004EP1444205A1 Method for producing 2-halogen-pyridine-carboxylic acid amides
08/11/2004EP1444197A1 Novel phenyl-propargylether derivatives
08/11/2004EP1444196A1 Novel alpha-oxygenated or alpha-thiolated carboxylic acid penethylamide derivatives
08/11/2004EP1444195A2 Process for the preparation of alpha-hydroxycarboxylic acid amides
08/11/2004EP1443929A2 Treatment of cns disorders using cns target modulators
08/11/2004EP1443928A2 Treatment of neurodegenerative diseases and cancer of the brain
08/11/2004EP1443926A1 Pyridine derivatives as nmda-receptor subtype blockers
08/11/2004EP1242390B1 Method for production of 1,3-disubstituted 2-nitroguanidines
08/11/2004EP1068196B1 Nitrate salt of anti-ulcer medicine
08/11/2004EP1066255B1 Method for producing lactams using oligophosphate catalysts
08/11/2004EP1056714B1 Phenylalanine derivatives as inhibitors of alpha4 integrins
08/11/2004EP1012142B1 2,3,5-trisubstituted pyridines as inhibitors of cyclooxygenase-2